Bullstar / Shutterstock.com
China has said that it will reduce the price of three top-selling patented drugs by more than 50%.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
China, Viread,Conmana, Iressa, Tenofovis Disoprox, Icotinib, Gefitnib, price reduction, patent,